#BEGIN_DRUGCARD DB03685

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
58-97-9

# ChEBI_ID:
16695

# Chemical_Formula:
C9H13N2O9P

# Chemical_IUPAC_Name:
{[(2S,3R,4R,5R)-5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}phosphonic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
5&#39;-Uridylic acid. A uracil nucleotide containing one phosphate group esterified to the sugar moiety in the 2&#39;, 3&#39; or 5&#39; position. [PubChem]

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Uridine-5'-Monophosphate

# HET_ID:
U25

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C9H13N2O9P/c12-5-1-2-11(9(15)10-5)8-7(14)6(13)4(20-8)3-19-21(16,17)18/h1-2,4,6-8,13-14H,3H2,(H,10,12,15)(H2,16,17,18)/t4-,6-,7+,8+/m0/s1

# InChI_Key:
InChIKey=DJJCXFVJDGTHFX-ZAKLUEHWSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
C00105

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
3685

# Mechanism_Of_Action:
Not Available

# Melting_Point:
202 dec Â°C

# Molecular_Weight_Avg:
324.1813

# Molecular_Weight_Mono:
324.035866536

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1LOJ

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-1.8

# Predicted_LogS:
-1.4

# Predicted_Water_Solubility:
1.20e+01 g/l

# Primary_Accession_No:
DB03685

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
6101904

# PubChem_Substance_ID:
46506409

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT03155

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
O[C@@H]1[C@@H](O)[C@@H](O[C@H]1COP(O)(O)=O)N1C=CC(=O)NC1=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:22:31 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_10_Cellular_Location:
Not Available

# Drug_Target_10_Chromosome_Location:
Not Available

# Drug_Target_10_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_10_Essentiality:
Non-Essential

# Drug_Target_10_GenAtlas_ID:
Not Available

# Drug_Target_10_GenBank_ID_Gene:
M59757

# Drug_Target_10_GenBank_ID_Protein:
143392

# Drug_Target_10_GeneCard_ID:
Not Available

# Drug_Target_10_Gene_Name:
pyrF

# Drug_Target_10_Gene_Sequence:
>720 bp
ATGAAAAACAACCTGCCCATCATCGCGCTTGATTTTGCGTCAGCTGAAGAAACACTTGCG
TTCTTAGCGCCTTTTCAGCAAGAACCGTTATTTGTAAAGGTTGGGATGGAGCTTTTTTAT
CAAGAAGGGCCATCTATCGTGAAACAACTAAAAGAAAGAAACTGCGAGCTATTTTTAGAT
CTAAAGCTTCATGACATCCCGACTACTGTAAACAAAGCGATGAAGCGCCTTGCCAGTCTT
GGAGTAGACCTCGTCAATGTTCATGCTGCCGGGGGCAAAAAAATGATGCAGGCAGCTCTC
GAAGGCTTAGAAGAAGGTACGCCGGCTGGAAAAAAACGTCCGTCACTTATCGCGGTAACC
CAGCTGACAAGCACATCTGAACAAATCATGAAAGATGAACTGCTGATCGAAAAGTCTCTG
ATTGATACGGTTGTGCACTACAGCAAACAGGCGGAAGAAAGCGGACTGGATGGAGTGGTC
TGCTCTGTTCATGAAGCAAAAGCCATTTACCAAGCGGTGTCGCCTTCATTTCTGACTGTC
ACTCCGGGGATCAGAATGTCAGAGGACGCTGCGAATGACCAAGTTCGCGTAGCGACGCCT
GCCATTGCAAGAGAGAAAGGTTCATCAGCGATTGTAGTAGGACGCTCGATTACAAAAGCG
GAAGACCCGGTAAAAGCCTATAAGGCTGTCAGACTTGAATGGGAGGGAATCAAATCTTGA

# Drug_Target_10_General_Function:
Nucleotide transport and metabolism

# Drug_Target_10_General_References:
10681442	Appleby TC, Kinsland C, Begley TP, Ealick SE: The crystal structure and mechanism of orotidine 5'-monophosphate decarboxylase. Proc Natl Acad Sci U S A. 2000 Feb 29;97(5):2005-10.
1709162	Quinn CL, Stephenson BT, Switzer RL: Functional organization and nucleotide sequence of the Bacillus subtilis pyrimidine biosynthetic operon. J Biol Chem. 1991 May 15;266(14):9113-27.
9384377	Kunst F, Ogasawara N, Moszer I, Albertini AM, Alloni G, Azevedo V, Bertero MG, Bessieres P, Bolotin A, Borchert S, Borriss R, Boursier L, Brans A, Braun M, Brignell SC, Bron S, Brouillet S, Bruschi CV, Caldwell B, Capuano V, Carter NM, Choi SK, Codani JJ, Connerton IF, Danchin A, et al.: The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature. 1997 Nov 20;390(6657):249-56.

# Drug_Target_10_HGNC_ID:
Not Available

# Drug_Target_10_HPRD_ID:
Not Available

# Drug_Target_10_ID:
3564

# Drug_Target_10_Locus:
Not Available

# Drug_Target_10_Molecular_Weight:
25992

# Drug_Target_10_Name:
Orotidine 5'-phosphate decarboxylase

# Drug_Target_10_Number_of_Residues:
239

# Drug_Target_10_PDB_ID:
1DBT

# Drug_Target_10_Pathway:
Not Available

# Drug_Target_10_Pfam_Domain_Function:
PF00215	OMPdecase

# Drug_Target_10_Protein_Sequence:
>Orotidine 5'-phosphate decarboxylase
MKNNLPIIALDFASAEETLAFLAPFQQEPLFVKVGMELFYQEGPSIVKQLKERNCELFLD
LKLHDIPTTVNKAMKRLASLGVDLVNVHAAGGKKMMQAALEGLEEGTPAGKKRPSLIAVT
QLTSTSEQIMKDELLIEKSLIDTVVHYSKQAEESGLDGVVCSVHEAKAIYQAVSPSFLTV
TPGIRMSEDAANDQVRVATPAIAREKGSSAIVVGRSITKAEDPVKAYKAVRLEWEGIKS

# Drug_Target_10_Reaction:
orotidine 5'-phosphate = UMP + CO2

# Drug_Target_10_Signals:
None

# Drug_Target_10_Specific_Function:
Catalyzes the decarboxylation of orotidine 5'- monophosphate (OMP) to uridine 5'-monophosphate (UMP)

# Drug_Target_10_SwissProt_ID:
P25971

# Drug_Target_10_SwissProt_Name:
PYRF_BACSU

# Drug_Target_10_Synonyms:
EC 4.1.1.23
OMP decarboxylase
OMPDCase
OMPdecase

# Drug_Target_10_Theoretical_pI:
6.15

# Drug_Target_10_Transmembrane_Regions:
None

# Drug_Target_11_Cellular_Location:
Not Available

# Drug_Target_11_Chromosome_Location:
Not Available

# Drug_Target_11_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_11_Essentiality:
Non-Essential

# Drug_Target_11_GenAtlas_ID:
Not Available

# Drug_Target_11_GenBank_ID_Gene:
X76083

# Drug_Target_11_GenBank_ID_Protein:
431230

# Drug_Target_11_GeneCard_ID:
Not Available

# Drug_Target_11_Gene_Name:
pyrR

# Drug_Target_11_Gene_Sequence:
>540 bp
ATGCAAAAGGCGGTCGTGATGGACGAACAGGCGATTCGCCGCGCTTTGACGCGCATCGCC
CACGAAATCATCGAACGAAACAAAGGCATTGACGGCTGCGTGCTTGTCGGAATTAAAACG
CGCGGCATTTACTTGGCGCGCCGCTTGGCGGAGCGGATCGAGCAAATTGAAGGGGCGTCC
GTTCCCGTCGGTGAGCTTGACATCACCTTGTACCGCGACGATTTGACCGTGAAGACGGAC
GACCATGAACCGCTTGTGAAAGGAACGAATGTGCCGTTTCCGGTGACCGAGCGGAATGTC
ATTTTAGTTGATGACGTGCTCTTCACCGGCCGGACGGTGCGGGCGGCGATGGATGCGGTC
ATGGATTTGGGCCGCCCGGCGCGCATCCAGCTCGCCGTGCTTGTTGACCGCGGCCACAGG
GAACTCCCGATCCGCGCTGATTTCGTCGGCAAAAACGTGCCGACCTCTCGTTCGGAACTG
ATCGTCGTGGAGCTTTCGGAAGTGGACGGCATCGATCAAGTCTCCATTCATGAAAAATAG

# Drug_Target_11_General_Function:
Nucleotide transport and metabolism

# Drug_Target_11_General_References:
8206848	Ghim SY, Neuhard J: The pyrimidine biosynthesis operon of the thermophile Bacillus caldolyticus includes genes for uracil phosphoribosyltransferase and uracil permease. J Bacteriol. 1994 Jun;176(12):3698-707.

# Drug_Target_11_HGNC_ID:
Not Available

# Drug_Target_11_HPRD_ID:
Not Available

# Drug_Target_11_ID:
2966

# Drug_Target_11_Locus:
Not Available

# Drug_Target_11_Molecular_Weight:
19938

# Drug_Target_11_Name:
PyrR bifunctional protein [Includes: Pyrimidine operon regulatory protein; Uracil phosphoribosyltransferase

# Drug_Target_11_Number_of_Residues:
179

# Drug_Target_11_PDB_ID:
1NON

# Drug_Target_11_Pathway:
Not Available

# Drug_Target_11_Pfam_Domain_Function:
PF00156	Pribosyltran

# Drug_Target_11_Protein_Sequence:
>PyrR bifunctional protein [Includes: Pyrimidine operon regulatory protein; Uracil phosphoribosyltransferase
MQKAVVMDEQAIRRALTRIAHEIIERNKGIDGCVLVGIKTRGIYLARRLAERIEQIEGAS
VPVGELDITLYRDDLTVKTDDHEPLVKGTNVPFPVTERNVILVDDVLFTGRTVRAAMDAV
MDLGRPARIQLAVLVDRGHRELPIRADFVGKNVPTSRSELIVVELSEVDGIDQVSIHEK

# Drug_Target_11_Reaction:
UMP + diphosphate = uracil + 5-phospho-alpha-D-ribose 1-diphosphate

# Drug_Target_11_Signals:
None

# Drug_Target_11_Specific_Function:
Displays also a weak uracil phosphoribosyltransferase activity which is not physiologically significant

# Drug_Target_11_SwissProt_ID:
P41007

# Drug_Target_11_SwissProt_Name:
PYRR_BACCL

# Drug_Target_11_Synonyms:
EC 2.4.2.9

# Drug_Target_11_Theoretical_pI:
5.71

# Drug_Target_11_Transmembrane_Regions:
None

# Drug_Target_12_Cellular_Location:
Not Available

# Drug_Target_12_Chromosome_Location:
Not Available

# Drug_Target_12_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_12_Essentiality:
Non-Essential

# Drug_Target_12_GenAtlas_ID:
Not Available

# Drug_Target_12_GenBank_ID_Gene:
BA000043

# Drug_Target_12_GenBank_ID_Protein:
56381745

# Drug_Target_12_GeneCard_ID:
Not Available

# Drug_Target_12_Gene_Name:
upp

# Drug_Target_12_Gene_Sequence:
>630 bp
TTATTTTGTGCCAAACAGCCGGTCGCCGGCGTCGCCGAGACCAGGGACAATATAGCCGTG
GTCGTTCAACCGCTCATCAAGGGCAGCGATGTAAATGTCCACATCCGGGTGGGCCGTTTC
CACCGCTTTGACTCCTTCCGGCGCCGCGATCAGGCACATAAATTTAATGCTTTTCGCTCC
CCGCTTTTTCAGCGCATCGATCGCCGCCACCGCTGATCCGCCGGTTGCGAGCATCGGGTC
GACGATGATAAAATCGCGCTCTTCGACATCGCTCGGCAGCTTGACGTAATATTCGACCGG
CTTTAATGTTTGGGGATCGCGGTACAAGCCGATATGGCCGACTTTCGCCGCCGGGATGAG
CTTCAGGATGCCGTCAACCATGCCGATGCCGGCGCGCAAAATCGGAATGACGCCCAGTTT
TTTGCCGGCGATCACTTTCGCTCTAGCTTTACTGACGGGGGTTTCGATCTCGACTTCCTC
AAGCGGCAGATCGCGTGTAATTTCAAACGCCATCAACGTCGCCACTTCGTCGACAAGCTC
GCGAAATTCTTTCGTGCCCGTATTCTTGTCGCGAATGTAGGTCAATTTATGCTGGATGAG
CGGATGATCAAAGACGTACACTTTTCCCAT

# Drug_Target_12_General_Function:
Nucleotide transport and metabolism

# Drug_Target_12_General_References:
Not Available

# Drug_Target_12_HGNC_ID:
Not Available

# Drug_Target_12_HPRD_ID:
Not Available

# Drug_Target_12_ID:
3575

# Drug_Target_12_Locus:
Not Available

# Drug_Target_12_Molecular_Weight:
22832

# Drug_Target_12_Name:
Uracil phosphoribosyltransferase

# Drug_Target_12_Number_of_Residues:
209

# Drug_Target_12_PDB_ID:
1I5E

# Drug_Target_12_Pathway:
Not Available

# Drug_Target_12_Pfam_Domain_Function:
PF00156	Pribosyltran

# Drug_Target_12_Protein_Sequence:
>Uracil phosphoribosyltransferase
MGKVYVFDHPLIQHKLTYIRDKNTGTKEFRELVDEVATLMAFEITRDLPLEEVEIETPVS
KARAKVIAGKKLGVIPILRAGIGMVDGILKLIPAAKVGHIGLYRDPQTLKPVEYYVKLPS
DVEERDFIIVDPMLATGGSAVAAIDALKKRGAKSIKFMCLIAAPEGVKAVETAHPDVDIY
IAALDERLNDHGYIVPGLGDAGDRLFGTK

# Drug_Target_12_Reaction:
UMP + diphosphate = uracil + 5-phospho-alpha-D-ribose 1-diphosphate

# Drug_Target_12_Signals:
None

# Drug_Target_12_Specific_Function:
UMP + diphosphate = uracil + 5-phospho-alpha- D-ribose 1-diphosphate

# Drug_Target_12_SwissProt_ID:
Q5KUI3

# Drug_Target_12_SwissProt_Name:
UPP_GEOKA

# Drug_Target_12_Synonyms:
EC 2.4.2.9
UMP pyrophosphorylase
UPRTase

# Drug_Target_12_Theoretical_pI:
6.69

# Drug_Target_12_Transmembrane_Regions:
None

# Drug_Target_13_Cellular_Location:
Not Available

# Drug_Target_13_Chromosome_Location:
Not Available

# Drug_Target_13_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_13_Essentiality:
Non-Essential

# Drug_Target_13_GenAtlas_ID:
Not Available

# Drug_Target_13_GenBank_ID_Gene:
AY057445

# Drug_Target_13_GenBank_ID_Protein:
16555376

# Drug_Target_13_GeneCard_ID:
Not Available

# Drug_Target_13_Gene_Name:
arnA

# Drug_Target_13_Gene_Sequence:
>1983 bp
ATGAAAACCGTCGTTTTTGCCTACCACGATATGGGATGCCTCGGTATTGAAGCCCTGCTG
GCTGCCGGTTACGAAATTAGCGCCATTTTTACCCATACTGATAATCCCGGTGAAAAAGCC
TTTTATGGTTCGGTGGCTCGTCTGGCGGCGGAAAGAGGCATTCCGGTTTATGCGCCGGAT
AACGTTAATCATCCGCTGTGGGTGGAACGCATTGCCCAACTGTCGCCAGATGTGATTTTC
TCTTTTTATTATCGCCATCTTATTTACGACGAAATTTTGCAGCTCGCTCCCGCAGGTGCA
TTTAATCTGCATGGTTCGCTGTTACCAAAATATCGTGGTCGCGCGCCGCTGAACTGGGTG
CTGGTCAACGGTGAAACGGAAACTGGCGTTACATTGCACCGAATGGTGAAACGTGCCGAT
GCCGGGGCCATTGTGGCGCAACTGCGCATTGCCATTGCGCCAGACGATATCGCTATTACG
CTGCATCATAAATTGTGCCATGCCGCGCGCCAGCTACTGGAACAGACATTACCCGCCATT
AAACACGGTAATATTCTGGAAATCGCCCAGCGCGAAAACGAAGCCACCTGTTTTGGTCGC
AGAACGCCGGATGACAGTTTCCTTGAATGGCATAAACCGGCATCCGTACTGCACAACATG
GTACGTGCCGTTGCCGATCCGTGGCCGGGTGCCTTCAGCTATGTTGGCAATCAGAAATTC
ACCGTCTGGTCGTCGCGTGTTCATCCTCATGCCAGCAAAGCACAGCCGGGGAGCGTGATT
TCTGTTGCGCCACTGCTGATTGCCTGTGGCGATGGCGCGCTGGAAATCGTCACCGGACAG
GCGGGCGACGGCATTACTATGCAGGGCTCGCAATTAGCGCAGACGCTGGGCCTGGTGCAA
GGTTCACGCTTGAATAGCCAGCCTGCCTGCACCGCCCGACGCCGTACCCGGGTACTCATC
CTCGGGGTGAATGGCTTTATTGGCAACCATCTGACAGAACGCCTGCTGCGCGAAGATCAT
TATGAAGTTTACGGTCTGGATATTGGCAGCGATGCGATAAGCCGTTTTCTGAATCATCCG
CATTTTCACTTTGTTGAAGGCGATATCAGTATTCATTCCGAATGGATTGAGTATCATGTC
AAAAAATGTGATGTCGTCTTGCCGCTGGTGGCGATAGCCACGCCGATTGAATATACCCGC
AACCCGCTGCGCGTATTTGAACTCGATTTTGAAGAGAATCTGCGCATTATCCGCTACTGC
GTGAAGTACCGTAAGCGAATCATCTTCCCGTCAACTTCAGAAGTTTATGGGATGTGTAGC
GATAAATACTTCGATGAGGACCATTCTAATTTAATCGTCGGCCCGGTGAATAAACCACGC
TGGATTTATTCGGTATCAAAACAATTACTTGATCGGGTGATCTGGGCCTATGGCGAAAAA
GAGGGTTTACAGTTCACCCTCTTCCGCCCGTTTAACTGGATGGGACCACGACTGGATAAC
CTTAATGCAGCGCGAATTGGCAGCTCCCGCGCTATTACGCAACTCATTCTCAATCTGGTA
GAAGGTTCACCGATTAAGCTGATTGATGGCGGAAAACAAAAACGCTGCTTTACTGATATT
CGCGATGGTATCGAGGCGTTATACCGCATTATCGAAAATGCGGGAAATCGCTGCGACGGT
GAAATTATCAACATTGGCAATCCTGAGAACGAAGCGAGCATTGAGGAACTGGGCGAGATG
CTGCTGGCGAGCTTCGAAAAACATCCGCTGCGCCATCATTTCCCACCGTTTGCGGGCTTT
CGCGTTGTCGAAAGTAGCAGCTACTACGGCAAAGGATATCAGGACGTAGAGCATCGTAAA
CCGAGCATCCGCAATGCCCACCGCTGCCTGGACTGGGAGCCGAAAATTGATATGCAGGAA
ACCATCGACGAAACGCTGGATTTCTTCCTGCGCACCGTTGATCTTACGGATAAACCATCA
TGA

# Drug_Target_13_General_Function:
Cell wall/membrane/envelope biogenesis

# Drug_Target_13_General_References:
11706007	Breazeale SD, Ribeiro AA, Raetz CR: Oxidative decarboxylation of UDP-glucuronic acid in extracts of polymyxin-resistant Escherichia coli. Origin of lipid a species modified with 4-amino-4-deoxy-L-arabinose. J Biol Chem. 2002 Jan 25;277(4):2886-96. Epub 2001 Nov 8.
9205837	Yamamoto Y, Aiba H, Baba T, Hayashi K, Inada T, Isono K, Itoh T, Kimura S, Kitagawa M, Makino K, Miki T, Mitsuhashi N, Mizobuchi K, Mori H, Nakade S, Nakamura Y, Nashimoto H, Oshima T, Oyama S, Saito N, Sampei G, Satoh Y, Sivasundaram S, Tagami H, Horiuchi T, et al.: Construction of a contiguous 874-kb sequence of the Escherichia coli -K12 genome corresponding to 50.0-68.8 min on the linkage map and analysis of its sequence features. DNA Res. 1997 Apr 28;4(2):91-113.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.

# Drug_Target_13_HGNC_ID:
Not Available

# Drug_Target_13_HPRD_ID:
Not Available

# Drug_Target_13_ID:
3257

# Drug_Target_13_Locus:
Not Available

# Drug_Target_13_Molecular_Weight:
74290

# Drug_Target_13_Name:
Bifunctional polymyxin resistance protein arnA

# Drug_Target_13_Number_of_Residues:
660

# Drug_Target_13_PDB_ID:
1U9J

# Drug_Target_13_Pathway:
Not Available

# Drug_Target_13_Pfam_Domain_Function:
PF00551	Formyl_trans_N
PF01370	Epimerase
PF02911	Formyl_trans_C

# Drug_Target_13_Protein_Sequence:
>Bifunctional polymyxin resistance protein arnA
MKTVVFAYHDMGCLGIEALLAAGYEISAIFTHTDNPGEKAFYGSVARLAAERGIPVYAPD
NVNHPLWVERIAQLSPDVIFSFYYRHLIYDEILQLAPAGAFNLHGSLLPKYRGRAPLNWV
LVNGETETGVTLHRMVKRADAGAIVAQLRIAIAPDDIAITLHHKLCHAARQLLEQTLPAI
KHGNILEIAQRENEATCFGRRTPDDSFLEWHKPASVLHNMVRAVADPWPGAFSYVGNQKF
TVWSSRVHPHASKAQPGSVISVAPLLIACGDGALEIVTGQAGDGITMQGSQLAQTLGLVQ
GSRLNSQPACTARRRTRVLILGVNGFIGNHLTERLLREDHYEVYGLDIGSDAISRFLNHP
HFHFVEGDISIHSEWIEYHVKKCDVVLPLVAIATPIEYTRNPLRVFELDFEENLRIIRYC
VKYRKRIIFPSTSEVYGMCSDKYFDEDHSNLIVGPVNKPRWIYSVSKQLLDRVIWAYGEK
EGLQFTLFRPFNWMGPRLDNLNAARIGSSRAITQLILNLVEGSPIKLIDGGKQKRCFTDI
RDGIEALYRIIENAGNRCDGEIINIGNPENEASIEELGEMLLASFEKHPLRHHFPPFAGF
RVVESSSYYGKGYQDVEHRKPSIRNAHRCLDWEPKIDMQETIDETLDFFLRTVDLTDKPS

# Drug_Target_13_Reaction:
Not Available

# Drug_Target_13_Signals:
None

# Drug_Target_13_Specific_Function:
Bifunctional enzyme that catalyzes the oxidative decarboxylation of UDP-glucuronic acid (UDP-GlcUA) to UDP-4-keto- arabinose (UDP-Ara4O) and the addition of a formyl group to UDP-4- amino-4-deoxy-L-arabinose (UDP-L-Ara4N) to form UDP-L-4-formamido- arabinose (UDP-L-Ara4FN). The modified arabinose is attached to lipid A and is required for resistance to polymyxin and cationic antimicrobial peptides

# Drug_Target_13_SwissProt_ID:
P77398

# Drug_Target_13_SwissProt_Name:
ARNA_ECOLI

# Drug_Target_13_Synonyms:
ArnAFT)
EC 1.1.1.-
EC 2.1.2.-
Polymyxin resistance protein pmrI
UDP-GlcUA decarboxylase
UDP-L-Ara4N formyltransferase
UDP-glucuronic acid dehydrogenase
UDP-glucuronic acid oxidase, UDP-4-keto-hexauronic acid decarboxylating

# Drug_Target_13_Theoretical_pI:
6.86

# Drug_Target_13_Transmembrane_Regions:
None

# Drug_Target_1_Cellular_Location:
Cytoplasmic

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
U00008

# Drug_Target_1_GenBank_ID_Protein:
Not Available

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
rsuA

# Drug_Target_1_Gene_Sequence:
Not Available

# Drug_Target_1_General_Function:
Translation, ribosomal structure and biogenesis

# Drug_Target_1_General_References:
10376875	Conrad J, Niu L, Rudd K, Lane BG, Ofengand J: 16S ribosomal RNA pseudouridine synthase RsuA of Escherichia coli: deletion, mutation of the conserved Asp102 residue, and sequence comparison among all other pseudouridine synthases. RNA. 1999 Jun;5(6):751-63.
11953756	Sivaraman J, Sauve V, Larocque R, Stura EA, Schrag JD, Cygler M, Matte A: Structure of the 16S rRNA pseudouridine synthase RsuA bound to uracil and UMP. Nat Struct Biol. 2002 May;9(5):353-8.
7612632	Wrzesinski J, Bakin A, Nurse K, Lane BG, Ofengand J: Purification, cloning, and properties of the 16S RNA pseudouridine 516 synthase from Escherichia coli. Biochemistry. 1995 Jul 11;34(27):8904-13.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
3706

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
25866

# Drug_Target_1_Name:
Ribosomal small subunit pseudouridine synthase A

# Drug_Target_1_Number_of_Residues:
231

# Drug_Target_1_PDB_ID:
1KSV

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00849	PseudoU_synth_2
PF01479	S4

# Drug_Target_1_Protein_Sequence:
>Ribosomal small subunit pseudouridine synthase A
MRLDKFIAQQLGVSRAIAGREIRGNRVTVDGEIVRNAAFKLLPEHDVAYDGNPLAQQHGP
RYFMLNKPQGYVCSTDDPDHPTVLYFLDEPVAWKLHAAGRLDIDTTGLVLMTDDGQWSHR
ITSPRHHCEKTYLVTLESPVADDTAEQFAKGVQLHNEKDLTKPAVLEVITPTQVRLTISE
GRYHQVKRMFAAVGNHVVELHRERIGGITLDADLAPGEYRPLTEEEIASVV

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Responsible for synthesis of pseudouridine from uracil- 516 in 16S ribosomal RNA

# Drug_Target_1_SwissProt_ID:
P0AA43

# Drug_Target_1_SwissProt_Name:
RSUA_ECOLI

# Drug_Target_1_Synonyms:
16S pseudouridine 516 synthase
16S pseudouridylate 516 synthase
EC 5.4.99.-
rRNA pseudouridylate synthase A
rRNA- uridine isomerase A

# Drug_Target_1_Theoretical_pI:
6.12

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Not Available

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
Not Available

# Drug_Target_2_GenBank_ID_Protein:
Not Available

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
UCKL1

# Drug_Target_2_Gene_Sequence:
Not Available

# Drug_Target_2_General_Function:
Not Available

# Drug_Target_2_General_References:
Not Available

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
7092

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
Not Available

# Drug_Target_2_Name:
Uridine-cytidine kinase-like 1

# Drug_Target_2_Number_of_Residues:
0

# Drug_Target_2_PDB_ID:
Not Available

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
Not Available

# Drug_Target_2_Protein_Sequence:
Not Available

# Drug_Target_2_Reaction:
Not Available

# Drug_Target_2_Signals:
Not Available

# Drug_Target_2_Specific_Function:
Not Available

# Drug_Target_2_SwissProt_ID:
Q9NWZ5

# Drug_Target_2_SwissProt_Name:
UCKL1_HUMAN

# Drug_Target_2_Synonyms:
Not Available

# Drug_Target_2_Theoretical_pI:
Not Available

# Drug_Target_2_Transmembrane_Regions:
Not Available

# Drug_Target_3_Cellular_Location:
Not Available

# Drug_Target_3_Chromosome_Location:
Not Available

# Drug_Target_3_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_3_Essentiality:
Non-Essential

# Drug_Target_3_GenAtlas_ID:
Not Available

# Drug_Target_3_GenBank_ID_Gene:
X06226

# Drug_Target_3_GenBank_ID_Protein:
41524

# Drug_Target_3_GeneCard_ID:
Not Available

# Drug_Target_3_Gene_Name:
galT

# Drug_Target_3_Gene_Sequence:
>1044 bp
ATGACGCAATTTAATCCCGTTGATCATCCACATCGCCGCTACAACCCGCTCACCGGGCAA
TGGATTCTGGTTTCACCGCACCGCCTAAGCCCCTGGCAGGGGGCGCAGGAAACGCCAGCC
AAACAGGTGTTACCTGCGCACGATCCAGATTGCTTCCTCTGCGCAGGTAATGTGCGGGTG
ACAGGCGATAAAAACCCCGATTACACCGGGACTTACGTTTTCACTAATGACTTTGCGGCT
TTGATGTCTGACACGCCAGATGCGCCAGAAAGTCACGATCCGCTGATGCGTTGCCAGAGC
GCGCGCGGCACCAGCCGGGTGATCTGCTTTTCACCGGATCACAGTAAAACGCTGCCAGAG
CTCAGCGTTGCAGCATTGACGGAAATCGTCAAAACCTGGCAGGAGCAAACCGCAGAACTG
GGGAAAACGTACCCATGGGTGCAGGTTTTTGAAAACAAAGGCGCGGCGATGGGCTGCTCT
AACCCGCATCCGCACGGTCAGATTTGGGCAAATAGCTTCCTGCCTAACGAAGCTGAGCGC
GAAGACCGCCTGCAAAAAGAATATTTTGCCGAACAGAAATCACCAATGCTGGTGGATTAT
GTTCAGCGCGAGCTGGCAGACGGTAGCCGTACCGTTGTCGAAACCGAACACTGGTTAGCC
GTCGTGCCTTACTGGGCTGCCTGGCCGTTCGAAACGCTACTGCTGCCCAAAGCCCACGTT
TTACGGATCACCGATTTGACCGACGCCCAGCGCAGCGATCTGGCGCTGGCGTTGAAAAAG
CTGACCAGTCGTTATGACAACCTCTTCCAGTGCTCCTTCCCCTACTCTATGGGCTGGCAC
GGCGCGCCATTTAATGGCGAAGAGAATCAACACTGGCAGCTGCACGCGCACTTTTATCCG
CCTCTGCTGCGCTCCGCCACCGTACGTAAATTTATGGTTGGTTATGAAATGCTGGCAGAG
ACCCAGCGAGACCTGACCGCAGAACAGGCAGCAGAGCGTTTGCGCGCAGTCAGCGACATC
CATTTTCGCGAATCCGGAGTGTAA

# Drug_Target_3_General_Function:
Carbohydrate transport and metabolism

# Drug_Target_3_General_References:
10820011	Geeganage S, Ling VW, Frey PA: Roles of two conserved amino acid residues in the active site of galactose-1-phosphate uridylyltransferase: an essential serine and a nonessential cysteine. Biochemistry. 2000 May 9;39(18):5397-404.
2823224	Cornwell TL, Adhya SL, Reznikoff WS, Frey PA: The nucleotide sequence of the gal T gene of Escherichia coli. Nucleic Acids Res. 1987 Oct 12;15(19):8116.
3022232	Lemaire HG, Muller-Hill B: Nucleotide sequences of the gal E gene and the gal T gene of E. coli. Nucleic Acids Res. 1986 Oct 10;14(19):7705-11.
3158881	Debouck C, Riccio A, Schumperli D, McKenney K, Jeffers J, Hughes C, Rosenberg M, Heusterspreute M, Brunel F, Davison J: Structure of the galactokinase gene of Escherichia coli, the last (?) gene of the gal operon. Nucleic Acids Res. 1985 Mar 25;13(6):1841-53.
321007	Wong LJ, Sheu KF, Lee SL, Frey PA: Galactose-1-phosphate uridylyltransferase: isolation and properties of a uridylyl-enzyme intermediate. Biochemistry. 1977 Mar 8;16(5):1010-6.
7669762	Wedekind JE, Frey PA, Rayment I: Three-dimensional structure of galactose-1-phosphate uridylyltransferase from Escherichia coli at 1.8 A resolution. Biochemistry. 1995 Sep 5;34(35):11049-61.
8794735	Wedekind JE, Frey PA, Rayment I: The structure of nucleotidylated histidine-166 of galactose-1-phosphate uridylyltransferase provides insight into phosphoryl group transfer. Biochemistry. 1996 Sep 10;35(36):11560-9.
8905232	Oshima T, Aiba H, Baba T, Fujita K, Hayashi K, Honjo A, Ikemoto K, Inada T, Itoh T, Kajihara M, Kanai K, Kashimoto K, Kimura S, Kitagawa M, Makino K, Masuda S, Miki T, Mizobuchi K, Mori H, Motomura K, Nakamura Y, Nashimoto H, Nishio Y, Saito N, Horiuchi T, et al.: A 718-kb DNA sequence of the Escherichia coli K-12 genome corresponding to the 12.7-28.0 min region on the linkage map. DNA Res. 1996 Jun 30;3(3):137-55.
9063869	Thoden JB, Ruzicka FJ, Frey PA, Rayment I, Holden HM: Structural analysis of the H166G site-directed mutant of galactose-1-phosphate uridylyltransferase complexed with either UDP-glucose or UDP-galactose: detailed description of the nucleotide sugar binding site. Biochemistry. 1997 Feb 11;36(6):1212-22.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.

# Drug_Target_3_HGNC_ID:
Not Available

# Drug_Target_3_HPRD_ID:
Not Available

# Drug_Target_3_ID:
2590

# Drug_Target_3_Locus:
Not Available

# Drug_Target_3_Molecular_Weight:
39646

# Drug_Target_3_Name:
Galactose-1-phosphate uridylyltransferase

# Drug_Target_3_Number_of_Residues:
348

# Drug_Target_3_PDB_ID:
1HXQ

# Drug_Target_3_Pathway:
Not Available

# Drug_Target_3_Pfam_Domain_Function:
PF01087	GalP_UDP_transf
PF02744	GalP_UDP_tr_C

# Drug_Target_3_Protein_Sequence:
>Galactose-1-phosphate uridylyltransferase
MTQFNPVDHPHRRYNPLTGQWILVSPHRAKRPWQGAQETPAKQVLPAHDPDCFLCAGNVR
VTGDKNPDYTGTYVFTNDFAALMSDTPDAPESHDPLMRCQSARGTSRVICFSPDHSKTLP
ELSVAALTEIVKTWQEQTAELGKTYPWVQVFENKGAAMGCSNPHPHGQIWANSFLPNEAE
REDRLQKEYFAEQKSPMLVDYVQRELADGSRTVVETEHWLAVVPYWAAWPFETLLLPKAH
VLRITDLTDAQRSDLALALKKLTSRYDNLFQCSFPYSMGWHGAPFNGEENQHWQLHAHFY
PPLLRSATVRKFMVGYEMLAETQRDLTAEQAAERLRAVSDIHFRESGV

# Drug_Target_3_Reaction:
UDP-glucose + alpha-D-galactose 1-phosphate = alpha-D-glucose 1-phosphate + UDP-galactose

# Drug_Target_3_Signals:
None

# Drug_Target_3_Specific_Function:
UDP-glucose + alpha-D-galactose 1-phosphate = alpha-D-glucose 1-phosphate + UDP-galactose

# Drug_Target_3_SwissProt_ID:
P09148

# Drug_Target_3_SwissProt_Name:
GAL7_ECOLI

# Drug_Target_3_Synonyms:
EC 2.7.7.12
Gal-1-P uridylyltransferase
UDP-glucose--hexose-1-phosphate uridylyltransferase

# Drug_Target_3_Theoretical_pI:
6.45

# Drug_Target_3_Transmembrane_Regions:
None

# Drug_Target_4_Cellular_Location:
Cytoplasm

# Drug_Target_4_Chromosome_Location:
Not Available

# Drug_Target_4_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_4_Essentiality:
Non-Essential

# Drug_Target_4_GenAtlas_ID:
Not Available

# Drug_Target_4_GenBank_ID_Gene:
M19653

# Drug_Target_4_GenBank_ID_Protein:
149601

# Drug_Target_4_GeneCard_ID:
Not Available

# Drug_Target_4_Gene_Name:
thyA

# Drug_Target_4_Gene_Sequence:
>990 bp
ATGTGTCGAGTAGTGAACGGTAAAGGAGCAGAGCAGACAATGTTAGAACAGCCATATCTT
GATCTTGCAAAAAAAGTTCTGGATGAAGGCCATTTCAAGCCTGATCGGACCCATACAGGA
ACTTACAGTATTTTCGGCCACCAAATGCGTTTCGACCTTAGCAAGGGCTTTCCATTACTG
ACGACCAAAAAAGTACCATTCGGCCTTATTAAGAGTGAGTTGTTGTGGTTTTTACACGGT
GATACCAACATTCGGTTCTTACTCCAACACAGGAATCACATTTGGGATGAGTGGGCGTTT
GAAAAATGGGTGAAGAGTGATGAATATCACGGCCCGGACATGACTGATTTTGGGCATCGC
AGCCAAAAGGATCCGGAATTCGCGGCAGTTTATCATGAAGAAATGGCTAAATTCGATGAC
CGGGTGCTTCATGATGATGCTTTTGCAGCCAAATATGGTGATCTTGGCTTGGTTTATGGA
TCCCAATGGCGGGCCTGGCATACGAGCAAGGGTGACACGATCGACCAGTTGGGGGACGTT
ATTGAGCAAATCAAAACGCATCCCTATTCACGACGGCTCATCGTGTCGGCGTGGAATCCG
GAAGATGTCCCGACAATGGCGCTACCGCCTTGTCACACGCTCTATCAGTTTTATGTCAAT
GATGGCAAGCTGTCTTTGCAGTTGTACCAACGTTCGGCTGACATTTTTCTTGGCGTCCCG
TTTAATATCGCGTCCTATGCGTTGTTAACGCATCTGGTCGCGCATGAATGTGGCCTTGAA
GTTGGCGAATTCATTCATACATTCGGCGATGCGCATCTTTACGTCAATCATCTTGACCAA
ATTAAAGAGCAGCTCAGTCGCACGCCGCGGCCGGCACCGACTTTACAGTTGAATCCGGAT
AAACATGATATTTTCGACTTTGACATGAAGGATATTAAGTTGCTTAATTACGATCCTTAT
CCGGCCATTAAGGCACCGGTTGCCGTTTAA

# Drug_Target_4_General_Function:
Nucleotide transport and metabolism

# Drug_Target_4_General_References:
105005	Maley GF, Bellisario RL, Guarino DU, Maley F: The primary structure of Lactobacillus casei thymidylate synthetase. III. The use of 2-(2-nitrophenylsulfenyl)-3-methyl-3-bromoindolenine and limited tryptic peptides to establish the complete amino acid sequence of the enzyme. J Biol Chem. 1979 Feb 25;254(4):1301-4.
2128651	Perry KM, Fauman EB, Finer-Moore JS, Montfort WR, Maley GF, Maley F, Stroud RM: Plastic adaptation toward mutations in proteins: structural comparison of thymidylate synthases. Proteins. 1990;8(4):315-33.
2840247	Pinter K, Davisson VJ, Santi DV: Cloning, sequencing, and expression of the Lactobacillus casei thymidylate synthase gene. DNA. 1988 May;7(4):235-41.
8371269	Finer-Moore J, Fauman EB, Foster PG, Perry KM, Santi DV, Stroud RM: Refined structures of substrate-bound and phosphate-bound thymidylate synthase from Lactobacillus casei. J Mol Biol. 1993 Aug 20;232(4):1101-16.
9383465	Kealey JT, Eckstein J, Santi DV: Role of the conserved tryptophan 82 of Lactobacillus casei thymidylate synthase. Chem Biol. 1995 Sep;2(9):609-14.

# Drug_Target_4_HGNC_ID:
Not Available

# Drug_Target_4_HPRD_ID:
Not Available

# Drug_Target_4_ID:
2729

# Drug_Target_4_Locus:
Not Available

# Drug_Target_4_Molecular_Weight:
36580

# Drug_Target_4_Name:
Thymidylate synthase

# Drug_Target_4_Number_of_Residues:
316

# Drug_Target_4_PDB_ID:
2TDM

# Drug_Target_4_Pathway:
Not Available

# Drug_Target_4_Pfam_Domain_Function:
PF00303	Thymidylat_synt

# Drug_Target_4_Protein_Sequence:
>Thymidylate synthase
MLEQPYLDLAKKVLDEGHFKPDRTHTGTYSIFGHQMRFDLSKGFPLLTTKKVPFGLIKSE
LLWFLHGDTNIRFLLQHRNHIWDEWAFEKWVKSDEYHGPDMTDFGHRSQKDPEFAAVYHE
EMAKFDDRVLHDDAFAAKYGDLGLVYGSQWRAWHTSKGDTIDQLGDVIEQIKTHPYSRRL
IVSAWNPEDVPTMALPPCHTLYQFYVNDGKLSLQLYQRSADIFLGVPFNIASYALLTHLV
AHECGLEVGEFIHTFGDAHLYVNHLDQIKEQLSRTPRPAPTLQLNPDKHDIFDFDMKDIK
LLNYDPYPAIKAPVAV

# Drug_Target_4_Reaction:
5,10-methylenetetrahydrofolate + dUMP = dihydrofolate + dTMP

# Drug_Target_4_Signals:
None

# Drug_Target_4_Specific_Function:
Provides the sole de novo source of dTMP for DNA biosynthesis

# Drug_Target_4_SwissProt_ID:
P00469

# Drug_Target_4_SwissProt_Name:
TYSY_LACCA

# Drug_Target_4_Synonyms:
EC 2.1.1.45
TS
TSase

# Drug_Target_4_Theoretical_pI:
6.28

# Drug_Target_4_Transmembrane_Regions:
None

# Drug_Target_5_Cellular_Location:
Not Available

# Drug_Target_5_Chromosome_Location:
Not Available

# Drug_Target_5_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_5_Essentiality:
Non-Essential

# Drug_Target_5_GenAtlas_ID:
Not Available

# Drug_Target_5_GenBank_ID_Gene:
Not Available

# Drug_Target_5_GenBank_ID_Protein:
Not Available

# Drug_Target_5_GeneCard_ID:
Not Available

# Drug_Target_5_Gene_Name:
GLT6D1

# Drug_Target_5_Gene_Sequence:
Not Available

# Drug_Target_5_General_Function:
Not Available

# Drug_Target_5_General_References:
Not Available

# Drug_Target_5_HGNC_ID:
Not Available

# Drug_Target_5_HPRD_ID:
Not Available

# Drug_Target_5_ID:
7011

# Drug_Target_5_Locus:
Not Available

# Drug_Target_5_Molecular_Weight:
Not Available

# Drug_Target_5_Name:
Glycosyltransferase 6 domain-containing protein 1

# Drug_Target_5_Number_of_Residues:
0

# Drug_Target_5_PDB_ID:
Not Available

# Drug_Target_5_Pathway:
Not Available

# Drug_Target_5_Pfam_Domain_Function:
Not Available

# Drug_Target_5_Protein_Sequence:
Not Available

# Drug_Target_5_Reaction:
Not Available

# Drug_Target_5_Signals:
Not Available

# Drug_Target_5_Specific_Function:
Not Available

# Drug_Target_5_SwissProt_ID:
Q7Z4J2

# Drug_Target_5_SwissProt_Name:
GL6D1_HUMAN

# Drug_Target_5_Synonyms:
Not Available

# Drug_Target_5_Theoretical_pI:
Not Available

# Drug_Target_5_Transmembrane_Regions:
Not Available

# Drug_Target_6_Cellular_Location:
Not Available

# Drug_Target_6_Chromosome_Location:
Not Available

# Drug_Target_6_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_6_Essentiality:
Non-Essential

# Drug_Target_6_GenAtlas_ID:
Not Available

# Drug_Target_6_GenBank_ID_Gene:
Not Available

# Drug_Target_6_GenBank_ID_Protein:
Not Available

# Drug_Target_6_GeneCard_ID:
Not Available

# Drug_Target_6_Gene_Name:
LSM6

# Drug_Target_6_Gene_Sequence:
Not Available

# Drug_Target_6_General_Function:
Not Available

# Drug_Target_6_General_References:
Not Available

# Drug_Target_6_HGNC_ID:
Not Available

# Drug_Target_6_HPRD_ID:
Not Available

# Drug_Target_6_ID:
6944

# Drug_Target_6_Locus:
Not Available

# Drug_Target_6_Molecular_Weight:
Not Available

# Drug_Target_6_Name:
U6 snRNA-associated Sm-like protein LSm6

# Drug_Target_6_Number_of_Residues:
0

# Drug_Target_6_PDB_ID:
Not Available

# Drug_Target_6_Pathway:
Not Available

# Drug_Target_6_Pfam_Domain_Function:
Not Available

# Drug_Target_6_Protein_Sequence:
Not Available

# Drug_Target_6_Reaction:
Not Available

# Drug_Target_6_Signals:
Not Available

# Drug_Target_6_Specific_Function:
Not Available

# Drug_Target_6_SwissProt_ID:
P62312

# Drug_Target_6_SwissProt_Name:
LSM6_HUMAN

# Drug_Target_6_Synonyms:
Not Available

# Drug_Target_6_Theoretical_pI:
Not Available

# Drug_Target_6_Transmembrane_Regions:
Not Available

# Drug_Target_7_Cellular_Location:
Not Available

# Drug_Target_7_Chromosome_Location:
Not Available

# Drug_Target_7_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_7_Essentiality:
Non-Essential

# Drug_Target_7_GenAtlas_ID:
Not Available

# Drug_Target_7_GenBank_ID_Gene:
AE000512

# Drug_Target_7_GenBank_ID_Protein:
4981245

# Drug_Target_7_GeneCard_ID:
Not Available

# Drug_Target_7_Gene_Name:
upp

# Drug_Target_7_Gene_Sequence:
>630 bp
ATGAAGAATCTCGTTGTGGTGGATCATCCCCTCATAAAGCACAAACTCACGATCATGAGA
GACAAGAACACCGGTCCGAAGGAGTTCAGAGAGCTGCTCAGAGAGATAACACTCCTCCTC
GCGTACGAAGCCACGAGACATTTGAAGTGCGAGGAAGTAGAGGTGGAAACTCCCATAACG
AAAACGATCGGATACCGTATAAACGATAAGGATATCGTGGTGGTTCCTATTCTCAGAGCC
GGTCTTGTGATGGCGGATGGTATTCTTGAACTGCTTCCAAACGCATCGGTGGGCCACATA
GGAATATACAGAGATCCGGAGACACTTCAAGCGGTGGAATACTACGCCAAGCTGCCTCCT
CTCAACGACGACAAAGAGGTCTTTTTGCTGGATCCCATGCTGGCGACGGGTGTTTCTTCG
ATAAAGGCCATCGAGATTTTGAAGGAGAACGGGGCGAAGAAGATCACGCTGGTGGCTCTG
ATCGCGGCTCCAGAGGGAGTGGAAGCGGTGGAGAAAAAATACGAAGATGTTAAAATCTAC
GTTGCAGCACTGGACGAGCGCCTCAACGATCACGGTTACATCATTCCTGGTCTTGGAGAT
GCGGGTGACAGACTCTTCAGGACAAAATAG

# Drug_Target_7_General_Function:
Cell wall/membrane/envelope biogenesis

# Drug_Target_7_General_References:
10360571	Nelson KE, Clayton RA, Gill SR, Gwinn ML, Dodson RJ, Haft DH, Hickey EK, Peterson JD, Nelson WC, Ketchum KA, McDonald L, Utterback TR, Malek JA, Linher KD, Garrett MM, Stewart AM, Cotton MD, Pratt MS, Phillips CA, Richardson D, Heidelberg J, Sutton GG, Fleischmann RD, Eisen JA, White O, Salzberg SL, Smith HO, Venter JC, Fraser CM: Evidence for lateral gene transfer between Archaea and bacteria from genome sequence of Thermotoga maritima. Nature. 1999 May 27;399(6734):323-9.

# Drug_Target_7_HGNC_ID:
Not Available

# Drug_Target_7_HPRD_ID:
Not Available

# Drug_Target_7_ID:
3600

# Drug_Target_7_Locus:
Not Available

# Drug_Target_7_Molecular_Weight:
23321

# Drug_Target_7_Name:
Uracil phosphoribosyltransferase

# Drug_Target_7_Number_of_Residues:
209

# Drug_Target_7_PDB_ID:
1O5O

# Drug_Target_7_Pathway:
Not Available

# Drug_Target_7_Pfam_Domain_Function:
PF00156	Pribosyltran

# Drug_Target_7_Protein_Sequence:
>Uracil phosphoribosyltransferase
MKNLVVVDHPLIKHKLTIMRDKNTGPKEFRELLREITLLLAYEATRHLKCEEVEVETPIT
KTIGYRINDKDIVVVPILRAGLVMADGILELLPNASVGHIGIYRDPETLQAVEYYAKLPP
LNDDKEVFLLDPMLATGVSSIKAIEILKENGAKKITLVALIAAPEGVEAVEKKYEDVKIY
VAALDERLNDHGYIIPGLGDAGDRLFRTK

# Drug_Target_7_Reaction:
UMP + diphosphate = uracil + 5-phospho-alpha-D-ribose 1-diphosphate

# Drug_Target_7_Signals:
None

# Drug_Target_7_Specific_Function:
UMP + diphosphate = uracil + 5-phospho-alpha- D-ribose 1-diphosphate

# Drug_Target_7_SwissProt_ID:
Q9WZI0

# Drug_Target_7_SwissProt_Name:
UPP_THEMA

# Drug_Target_7_Synonyms:
EC 2.4.2.9
UMP pyrophosphorylase
UPRTase

# Drug_Target_7_Theoretical_pI:
5.70

# Drug_Target_7_Transmembrane_Regions:
None

# Drug_Target_8_Cellular_Location:
Golgi stack
Golgi stack membrane
Isoform Long, isoform Short:Golgi apparatus
single-pass type II

# Drug_Target_8_Chromosome_Location:
Not Available

# Drug_Target_8_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_8_Essentiality:
Non-Essential

# Drug_Target_8_GenAtlas_ID:
B4GALT1

# Drug_Target_8_GenBank_ID_Gene:
X14085

# Drug_Target_8_GenBank_ID_Protein:
29424

# Drug_Target_8_GeneCard_ID:
B4GALT1

# Drug_Target_8_Gene_Name:
B4GALT1

# Drug_Target_8_Gene_Sequence:
>1203 bp
ATGAGGCTTCGGGAGCCGCTCCTGAGCGGCGCCGCGATGCCAGGCGCGTCCCTACAGCGG
GCCTGCCGCCTGCTCGTGGCCGTCTGCGCTCTGCACCTTGGCGTCACCCTCGTTTACTAC
CTGGCTGGCCGCGACCTGAGCCGCCTGCCCCAACTGGTCGGAGTCTCCACACCGCTGCAG
GGCGGCTCGAACAGTGCCGCCGCCATCGGGCAGTCCTCCGGGGAGCTCCGGACCGGAGGG
GCCCGGCCGCCGCCTCCTCTAGGCGCCTCCTCCCAGCCGCGCCCGGGTGGCGACTCCAGC
CCAGTCGTGGATTCTGGCCCTGGCCCCGCTAGCAACTTGACCTCGGTCCCAGTGCCCCAC
ACCACCGCACTGTCGCTGCCCGCCTGCCCTGAGGAGTCCCCGCTGCTTGTGGGCCCCATG
CTGATTGAGTTTAACATGCCTGTGGACCTGGAGCTCGTGGCAAAGCAGAACCCAAATGTG
AAGATGGGCGGCCGCTATGCCCCCAGGGACTGCGTCTCTCCTCACAAAGTGGCCATCATC
ATTCCATTCCGCAACCGGCAGGAGCACCTCAAGTACTGGCTATATTATTTGCACCCAGTC
CTGCAGCGCCAGCAGCTGGACTATGGCATCTATGGCATCTATGTTATCAACCAGGCGGGA
GACACTATATTCAATCGTGCTAAGCTCCTCAATGTTGGCTTTCAAGAAGCCTTGAAGGAC
TATGACTACACCTGCTTTGTGTTTAGTGACGTGGACCTCATCCCAATGAATGACCATAAT
GCGTACAGGTGTTTTTCACAGCCACGGCACATTTCCGTTGCAATGGATAAGTTTGGATTC
AGCCTACCTTATGTTCAGTATTTTGGAGGTGTCTCTGCTCTAAGTAAACAACAGTTTCTA
ACCATCAATGGATTTCCTAATAATTATTGGGGCTGGGGAGGAGAAGATGATGACATTTTT
AACAGATTAGTTTTTAGAGGCATGTCTATATCTCGCCCAAATGCTGTGGTCGGGAGGTGT
CGCATGATCCGCCACTCAAGAGACAAAAAAAATGAACCCAATCCTCAGAGGTTTGACCGA
ATTGCACACACAAAGGAGACAATGCTCTCTGATGGTTTGAACTCACTCACCTACCAGGTG
CTGGATGTACAGAGATACCCATTGTATACCCAAATCACAGTGGACATCGGGACACCGAGC
TAG

# Drug_Target_8_General_Function:
Involved in transferase activity, transferring glycosyl groups

# Drug_Target_8_General_References:
10580128	Amado M, Almeida R, Schwientek T, Clausen H: Identification and characterization of large galactosyltransferase gene families: galactosyltransferases for all functions. Biochim Biophys Acta. 1999 Dec 6;1473(1):35-53.
1384956	Uejima T, Uemura M, Nozawa S, Narimatsu H: Complementary DNA cloning for galactosyltransferase associated with tumor and determination of antigenic epitopes recognized by specific monoclonal antibodies. Cancer Res. 1992 Nov 15;52(22):6158-63.
1714903	Lopez LC, Youakim A, Evans SC, Shur BD: Evidence for a molecular distinction between Golgi and cell surface forms of beta 1,4-galactosyltransferase. J Biol Chem. 1991 Aug 25;266(24):15984-91.
1903938	Mengle-Gaw L, McCoy-Haman MF, Tiemeier DC: Genomic structure and expression of human beta-1,4-galactosyltransferase. Biochem Biophys Res Commun. 1991 May 15;176(3):1269-76.
2120039	Aoki D, Appert HE, Johnson D, Wong SS, Fukuda MN: Analysis of the substrate binding sites of human galactosyltransferase by protein engineering. EMBO J. 1990 Oct;9(10):3171-8.
2124683	Watzele G, Berger EG: Near identity of HeLa cell galactosyltransferase with the human placental enzyme. Nucleic Acids Res. 1990 Dec 11;18(23):7174.
3091013	Appert HE, Rutherford TJ, Tarr GE, Thomford NR, McCorquodale DJ: Isolation of galactosyltransferase from human milk and the determination of its N-terminal amino acid sequence. Biochem Biophys Res Commun. 1986 Jul 16;138(1):224-9.
3094506	Appert HE, Rutherford TJ, Tarr GE, Wiest JS, Thomford NR, McCorquodale DJ: Isolation of a cDNA coding for human galactosyltransferase. Biochem Biophys Res Commun. 1986 Aug 29;139(1):163-8.
3144273	Masri KA, Appert HE, Fukuda MN: Identification of the full-length coding sequence for human galactosyltransferase (beta-N-acetylglucosaminide: beta 1,4-galactosyltransferase). Biochem Biophys Res Commun. 1988 Dec 15;157(2):657-63.
7540104	Chatterjee SK, Mukerjee S, Tripathi PK: Analysis of the sequences of human beta-1,4-galactosyltransferase cDNA clones. Int J Biochem Cell Biol. 1995 Mar;27(3):329-36.
7579794	Kudo T, Narimatsu H: The beta 1,4-galactosyltransferase gene is post-transcriptionally regulated during differentiation of mouse F9 teratocarcinoma cells. Glycobiology. 1995 Jun;5(4):397-403.
7744867	Yamaguchi N, Fukuda MN: Golgi retention mechanism of beta-1,4-galactosyltransferase. Membrane-spanning domain-dependent homodimerization and association with alpha- and beta-tubulins. J Biol Chem. 1995 May 19;270(20):12170-6.

# Drug_Target_8_HGNC_ID:
HGNC:924

# Drug_Target_8_HPRD_ID:
00659

# Drug_Target_8_ID:
287

# Drug_Target_8_Locus:
9p13

# Drug_Target_8_Molecular_Weight:
43921

# Drug_Target_8_Name:
Beta-1,4-galactosyltransferase 1

# Drug_Target_8_Number_of_Residues:
398

# Drug_Target_8_PDB_ID:
1FR8

# Drug_Target_8_Pathway:
Not Available

# Drug_Target_8_Pfam_Domain_Function:
PF02709	Galactosyl_T_2

# Drug_Target_8_Protein_Sequence:
>Beta-1,4-galactosyltransferase 1
MRLREPLLSGSAAMPGASLQRACRLLVAVCALHLGVTLVYYLAGRDLSRLPQLVGVSTPL
QGGSNSAAAIGQSSGELRTGGARPPPPLGASSQPRPGGDSSPVVDSGPGPASNLTSVPVP
HTTALSLPACPEESPLLVGPMLIEFNMPVDLELVAKQNPNVKMGGRYAPRDCVSPHKVAI
IIPFRNRQEHLKYWLYYLHPVLQRQQLDYGIYVINQAGDTIFNRAKLLNVGFQEALKDYD
YTCFVFSDVDLIPMNDHNAYRCFSQPRHISVAMDKFGFSLPYVQYFGGVSALSKQQFLTI
NGFPNNYWGWGGEDDDIFNRLVFRGMSISRPNAVVGRCRMIRHSRDKKNEPNPQRFDRIA
HTKETMLSDGLNSLTYQVLDVQRYPLYTQITVDIGTPS

# Drug_Target_8_Reaction:
UDP-galactose + D-glucose = UDP + lactose

# Drug_Target_8_Signals:
None

# Drug_Target_8_Specific_Function:
The cell surface form functions as a recognition molecule during a variety of cell to cell and cell to matrix interactions, as those occurring during development and egg fertilization, by binding to specific oligosaccharide ligands on opposing cells or in the extracellular matrix

# Drug_Target_8_SwissProt_ID:
P15291

# Drug_Target_8_SwissProt_Name:
B4GT1_HUMAN

# Drug_Target_8_Synonyms:
Beta-1,4-GalTase 1
Beta4Gal-T1
EC 2.4.1.-
EC 2.4.1.22
EC 2.4.1.90
N-acetyllactosamine synthase
UDP-Gal:beta-GlcNAc beta-1,4- galactosyltransferase 1
UDP-galactose:beta-N-acetylglucosamine beta- 1,4-galactosyltransferase 1
b4Gal-T1

# Drug_Target_8_Theoretical_pI:
8.77

# Drug_Target_8_Transmembrane_Regions:
25-44

# Drug_Target_9_Cellular_Location:
Nucleus

# Drug_Target_9_Chromosome_Location:
Not Available

# Drug_Target_9_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_9_Essentiality:
Non-Essential

# Drug_Target_9_GenAtlas_ID:
ISG20

# Drug_Target_9_GenBank_ID_Gene:
X89773

# Drug_Target_9_GenBank_ID_Protein:
6759541

# Drug_Target_9_GeneCard_ID:
ISG20

# Drug_Target_9_Gene_Name:
ISG20

# Drug_Target_9_Gene_Sequence:
>546 bp
ATGGCTGGGAGCCGTGAGGTGGTGGCCATGGACTGCGAGATGGTGGGGCTGGGGCCCCAC
CGGGAGAGTGGCCTGGCTCGTTGCAGCCTCGTGAACGTCCACGGTGCTGTGCTGTACGAC
AAGTTCATCCGGCCTGAGGGAGAGATCACCGATTACAGAACCCGGGTCAGCGGGGTCACC
CCTCAGCACATGGTGGGGGCCACACCATTTGCCGTGGCCAGGCTAGAGATCCTGCAGCTC
CTGAAAGGCAAGCTGGTGGTGGGTCATGACCTGAAGCACGACTTCCAGGCACTGAAAGAG
GACATGAGCGGCTACACAATCTACGACACGTCCACTGACAGGCTGTTGTGGCGTGAGGCC
AAGCTGGACCACTGCAGGCGTGTCTCCCTGCGGGTGCTGAGTGAGCGCCTCCTGCACAAG
AGCATCCAGAACAGCCTGCTTGGACACAGCTCGGTGGAAGATGCGAGGGCAACGATGGAG
CTCTATCAAATCTCCCAGAGAATCCGAGCCCGCCGAGGGCTGCCCCGCCTGGCTGTGTCA
GACTGA

# Drug_Target_9_General_Function:
Replication, recombination and repair

# Drug_Target_9_General_References:
9235947	Gongora C, David G, Pintard L, Tissot C, Hua TD, Dejean A, Mechti N: Molecular cloning of a new interferon-induced PML nuclear body-associated protein. J Biol Chem. 1997 Aug 1;272(31):19457-63.

# Drug_Target_9_HGNC_ID:
HGNC:6130

# Drug_Target_9_HPRD_ID:
05169

# Drug_Target_9_ID:
3529

# Drug_Target_9_Locus:
15q26

# Drug_Target_9_Molecular_Weight:
20364

# Drug_Target_9_Name:
Interferon-stimulated gene 20 kDa protein

# Drug_Target_9_Number_of_Residues:
181

# Drug_Target_9_PDB_ID:
1WLJ

# Drug_Target_9_Pathway:
Not Available

# Drug_Target_9_Pfam_Domain_Function:
PF00929	Exonuc_X-T

# Drug_Target_9_Protein_Sequence:
>Interferon-stimulated gene 20 kDa protein
MAGSREVVAMDCEMVGLGPHRESGLARCSLVNVHGAVLYDKFIRPEGEITDYRTRVSGVT
PQHMVGATPFAVARLEILQLLKGKLVVGHDLKHDFQALKEDMSGYTIYDTSTDRLLWREA
KLDHCRRVSLRVLSERLLHKSIQNSLLGHSSVEDARATMELYQISQRIRARRGLPRLAVS
D

# Drug_Target_9_Reaction:
Exonucleolytic cleavage in the 3'- to 5'-direction to yield nucleoside 5'-phosphates

# Drug_Target_9_Signals:
None

# Drug_Target_9_Specific_Function:
Exonuclease with specificity for single-stranded RNA and, to a lesser extent for DNA. Degrades RNA at a rate that is approximately 35-fold higher than its rate for single-stranded DNA. Involved in the antiviral function of IFN against RNA viruses

# Drug_Target_9_SwissProt_ID:
Q96AZ6

# Drug_Target_9_SwissProt_Name:
ISG20_HUMAN

# Drug_Target_9_Synonyms:
EC 3.1.13.1
Estrogen-regulated transcript 45 protein
Promyelocytic leukemia nuclear body-associated protein ISG20

# Drug_Target_9_Theoretical_pI:
9.19

# Drug_Target_9_Transmembrane_Regions:
None

#END_DRUGCARD DB03685
